T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$2.31B |
| 2 |
Apple
AAPL
|
+$1.58B |
| 3 |
Sherwin-Williams
SHW
|
+$1.37B |
| 4 |
HubSpot
HUBS
|
+$1.32B |
| 5 |
Kenvue
KVUE
|
+$1.25B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.37B |
| 2 |
Lam Research
LRCX
|
+$1.54B |
| 3 |
Applied Materials
AMAT
|
+$1.33B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.19B |
| 5 |
Halliburton
HAL
|
+$1.16B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.32% |
| 2 | Healthcare | 15.15% |
| 3 | Financials | 10.54% |
| 4 | Consumer Discretionary | 10.48% |
| 5 | Communication Services | 8.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
General Motors
GM
$75.8B
| $109M | 0.01% |
2,427,776
-3,973,021
| -62% | -$184M |
|
552
Replimune Group
REPL
$1.42B
| $108M | 0.01% |
9,879,250
+643,193
| +7% | +$6.53M |
|
553
Rivian
RIVN
$22.9B
| $108M | 0.01% |
9,637,071
-46,269,063
| -83% | -$665M |
|
554
ON Semiconductor
ON
$31.8B
| $108M | 0.01% |
1,486,631
+757,121
| +104% | +$55.1M |
|
555
NetEase
NTES
$78.5B
| $107M | 0.01% |
1,145,463
-195,092
| -15% | -$17M |
|
556
Arthur J. Gallagher & Co
AJG
$65B
| $107M | 0.01% |
380,148
-60,589
| -14% | -$17.1M |
|
557
Baidu
BIDU
$35.5B
| $107M | 0.01% |
1,013,912
+3,273
| +0.3% | +$289K |
|
558
Upwork
UPWK
$1.08B
| $107M | 0.01% |
10,209,195
+8,161,045
| +398% | +$85.1M |
|
559
BP
BP
$110B
| $106M | 0.01% |
3,392,683
-3,348,135
| -50% | -$113M |
|
560
Guidewire Software
GWRE
$15.2B
| $105M | 0.01% |
575,341
+189,902
| +49% | +$28.8M |
|
561
Fabrinet
FN
$20.3B
| $103M | 0.01% |
437,465
-34,098
| -7% | -$7.89M |
|
562
Galicia Financial Group
GGAL
$7.23B
| $101M | 0.01% |
2,409,176
+920,508
| +62% | +$32M |
|
563
United Rentals
URI
$69.7B
| $101M | 0.01% |
124,741
+352
| +0.3% | +$253K |
|
564
Petrobras
PBR
$115B
| $100M | 0.01% |
6,967,821
-1,748,484
| -20% | -$25.7M |
|
565
Delta Air Lines
DAL
$60B
| $99.2M | 0.01% |
1,952,848
+1,058,670
| +118% | +$46.1M |
|
566
Air Products & Chemicals
APD
$68B
| $98.3M | 0.01% |
330,299
+913
| +0.3% | +$250K |
|
567
Celldex Therapeutics
CLDX
$3.35B
| $97.9M | 0.01% |
2,880,365
-292,034
| -9% | -$11.1M |
|
568
IQVIA
IQV
$39.8B
| $97.9M | 0.01% |
413,010
-166,813
| -29% | -$39.4M |
|
569
Moderna
MRNA
$25.4B
| $97.6M | 0.01% |
1,459,979
-139,749
| -9% | -$12.8M |
|
570
Iron Mountain
IRM
$37.7B
| $97.5M | 0.01% |
820,134
+187,308
| +30% | +$20M |
|
571
Deckers Outdoor
DECK
$12.7B
| $97.2M | 0.01% |
609,489
+42,579
| +8% | +$6.5M |
|
|
LBPH
572
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
| $97M | 0.01% |
2,909,257
+400,721
| +16% | +$13.8M |
|
573
Paychex
PAYX
$44.6B
| $96.8M | 0.01% |
720,997
-212,340
| -23% | -$27M |
|
574
CDW
CDW
$17.8B
| $96.6M | 0.01% |
426,834
+22,326
| +6% | +$4.96M |
|
575
Ciena
CIEN
$62.7B
| $96.3M | 0.01% |
1,563,270
+255,544
| +20% | +$13.5M |
|
Similar funds
T. Rowe Price Associates's Q3 2024 Portfolio in Review
As of Q3 2024, T. Rowe Price Associates held 3,059 positions worth $869B, up 3.9% from $836B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Trading was light in Q3 2024: portfolio turnover was 4.3%. T. Rowe Price Associates opened 82 new positions and exited 51, leaving the 3,059-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 34% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q3 2024 buy was Lineage Inc: 4,699,854 shares worth $368M.
- T. Rowe Price Associates added most to Advanced Micro Devices in Q3 2024, an estimated $2.31B increase.
- T. Rowe Price Associates's biggest Q3 2024 reduction was NVIDIA, cutting an estimated $4.37B.
- T. Rowe Price Associates fully exited Morphic Holding, Inc. Common Stock in Q3 2024, selling an estimated $75.2M.
- T. Rowe Price Associates's ten largest holdings make up 34% of its $869B portfolio in Q3 2024.
- T. Rowe Price Associates opened 82 new positions and closed 51 in Q3 2024.
- T. Rowe Price Associates's portfolio value rose 3.9% quarter-over-quarter to $869B.
Based on T. Rowe Price Associates's 13F filing for Q3 2024, filed 14 Nov 2024.